APOE and Alzheimer disease: These findings are consistent with the antagonistic pleiotropy effects of APOE-ε4, since our MCI patients are relatively younger than the typical AD patients, and may still be able to utilize their cogntive and neural reseve (Tuminello and Han, 2011; Chang et al., 2016).